Skip to Main Content

Paper Details

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers.
0
2023
AIDS, CAB, CD4, HIV, Human Immunodeficiency Virus, PWH, People, RPV, WS, cabotegravir, integrase, people, person, rilpivirine
Author NameAffiliation
Paul E SaxHarvard Medical School
Paul E SaxBrigham and Women's Hospital
Joseph J EronMassachusetts General Hospital
Joseph J EronUniversity of North Carolina at Chapel Hill
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergHarvard Medical School
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergCenter for AIDS Research, Harvard University
Kenneth A FreedbergMassachusetts General Hospital
Kenneth A FreedbergHarvard T. H. Chan School of Public Health
  • 1 - 10

Datasets

Release 1.2